Castleman lymphadenopathy: case review

Authors

DOI:

https://doi.org/10.26641/1997-9665.2020.4.29-34

Keywords:

Castleman-like lymphadenopathy, regional lymph nodes, rectal cancer

Abstract

Background. While examining regional lymph nodes removed with the tumor, the pathomorphologist is often limited to the exclusion of metastases, omitting changes in lymphoid tissue. The aim of the work is to describe a rare variant of Castleman-like lymphadenopathy in the surgical material obtained during the removal of colon cancer with regional lymph nodes. Methods. Pathomorphological examination of removed lymph nodes using histological and immunohistochemical methods (CD23). Results. A 73-year-old patient underwent surgery for rectal cancer. Pathomorphological analysis diagnosed adenocarcinoma of high degree of differentiation (G1) and revealed Castleman-like changes in some of the enlarged regional mesenteric lymph nodes: signs of different stages of development of lymphoid follicles, including their hyperplasia, atresia and fragmentation with preservation of activated CD23+ follicular dendritic cells and reaction of microvasculature, including vascular proliferation in the interfollicular areas with uneven narrowing of the sinuses. The discussion analyzes the probable genesis of changes in lymphoid tissue, which may be a reflection of the early stage of Castleman's disease, complication of radiation therapy performed in the preoperative stage, or a consequence of impaired immune status due to tumor growth, in particular with antigenic overloading of draining lymphoid tissue, effects of cytokines produced by inflammatory infiltrate cells that accumulate directly near the tumor, and the formation of a state of genetic instability, which progresses under the influence of radiation. Conclusion. Despite the rarity of Castleman-like lymphadenopathy, in each case of examination of lymph nodes in the surgical material it is necessary to conduct a thorough analysis of lymphoid tissue, as this may be important both to assess the prognosis and to select adequate therapy.

References

  1. Saidha NK1, Mehta R1, Malhotra M1, Singh AK1, Kumar D1, Sharma CP1. Sentinel Lymph Node Biopsy in Colon Cancer: an Institutional Experience. Indian J Surg Oncol. 2019 Dec;10(4):632-9. doi: 10.1007/s13193-019-00957-y.
  2. Mogoantă SŞ1, Calotă F, Vasile I, Crafciuc AV, Gherghinescu MC, Sapalidis K, Ilie DS, Ion DA. Histological and immunohistochemical study on sentinel lymph node in colorectal cancer - values and limitations. Rom J Morphol Embryol. 2016;57(1):65-74.
  3. Valladolid G, Weisenberg E, Sundaresan R, Maker AV. Calcifying fibrous tumor of the small intestine associated with Castleman-like lymphadenopathy. J Gastrointest Surg. 2014 Jun;18(6):1205-8. doi: 10.1007/s11605-014-2458-8.
  4. Chen YR, Chen YJ, Wang MC, Medeiros LJ, Chang KC. A Newly Recognized Histologic Pattern of IgG4-related Lymphadenopathy: Expanding the Morphologic Spectrum. Am J Surg Pathol. 2018 Jul;42(7):977-982. doi: 10.1097/PAS.0000000000001076.
  5. Zhou YX, Ji Y, Wu S A CARE-compliant article: Unicentric Castleman disease presenting as a retroperitoneal mass of the upper edge of the pancreas: A case report. Medicine (Baltimore). 2020 Mar;99(11):e19515. doi: 10.1097/MD.0000000000019515.
  6. Cheng JL, Cui J, Wang Y, Xu ZZ, Liu F, Liang SB, Tian H. Unicentric Castleman disease presenting as a retroperitoneal peripancreatic mass: A report of two cases and review of literature. World J Gastroenterol. 2018 Sep 14;24(34):3958-3964. doi: 10.3748/wjg.v24.i34.3958.
  7. Li P, Liu H, Li H, Li A, Yu G, Yin W. Hyaline vascular variant of unicentric Castleman disease of the tonsil: a case report. Diagn Pathol. 2019 Jun 29;14(1):70. doi: 10.1186/s13000-019-0836-y.
  8. Otsuka M, Koga T, Sumiyoshi R, Okamoto M, Endo Y, Tsuji S, Takatani A, Shimizu T, Igawa T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Daisuke N, Kawakami A. Rheumatoid arthritis-like active synovitis with T-cell activation in a case of idiopathic multicentric Castleman disease: A case report. Medicine (Baltimore). 2019 May;98(18):e15237. doi: 10.1097/MD.0000000000015237.
  9. Gars E, Butzmann A, Ohgami R, Balakrishna JP, O'Malley DP. The life and death of the germinal center. Ann Diagn Pathol. 2020 Feb;44:151421. doi: 10.1016/j.anndiagpath.2019.151421.
  10. Szalat R, Munshi NC. Diagnosis of Castleman Disease. Hematol Oncol Clin North Am. 2018 Feb;32(1):53-64. doi: 10.1016/j.hoc.2017.09.005.
  11. Wu D, Lim MS, Jaffe ES. Pathology of Castleman Disease. Hematol Oncol Clin North Am. 2018 Feb;32(1):37-52. doi: 10.1016/j.hoc.2017.09.004.
  12. Sevilla-Lizcano DB, Frias-Soria CL, Ortiz-Hidalgo C. Castleman disease. Histopathological and immunohistochemical analysis of 39 cases. Gac Med Mex. 2017;153(5):550-8. doi: 10.24875/GMM.17003021.
  13. Barna B, Sabri S, Chitnis A, Arora P, Hunt R. Castleman's disease: A rare cause of an axillary mass mimicking breast metastasis. Breast J. 2019 Jan;25(1):147-8. doi: 10.1111/tbj.13179.
  14. Wong RSM1. Unicentric Castleman Disease. Hematol Oncol Clin North Am. 2018 Feb;32(1):65-73. doi: 10.1016/j.hoc.2017.09.006.
  15. Paydas S. Tafro syndrome: Critical review for clinicians and pathologists. Crit Rev Oncol Hematol. 2018 Aug;128:88-95. doi: 10.1016/j.critrevonc.2018.05.015.
  16. Wang W, Medeiros LJ. Castleman Disease. Surg Pathol Clin. 2019 Sep;12(3):849-863. doi: 10.1016/j.path.2019.03.003.
  17. Koh J, Jeon YK. Morphologic variant of follicular lymphoma reminiscent of hyaline-vascular Castleman disease. J Pathol Transl Med. 2020 Feb 5. doi: 10.4132/jptm.2019.12.17.

Downloads

Published

2021-09-25

How to Cite

Gavrilyuk, O. M., Tomashova, S. A., & Stolіar H. L. (2021). Castleman lymphadenopathy: case review. Морфологія / Morphologia / Morfologìâ, 14(4), 29–34. https://doi.org/10.26641/1997-9665.2020.4.29-34

Issue

Vol. 14 No. 4 (2020)

Section

Статті

License

Copyright (c) 2021 Morphologia

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

 The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.
        By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world. 
        The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.